Although Parkinson’s disease does not have a known cure, there are ways to treat and manage it. There are many components of treatments of Parkinson’s disease such as patient’s age, cognitive, life style, and symptom severity (Lyons & Pahwa, 2011, p. 29). With those components known, treatment can be modified based on the patient’s case. Treatment of Parkinson’s disease includes prescription drugs and non-pharmacologic treatment. One of the ways to manage Parkinson’s disease is prescription drugs. There are three common drugs that are used for management and treatment of Parkinson’s disease. The three frequent drugs that are used are Levodopa, Dopamine agonists and MAO-B inhibitor.
The first prescription drug is called Levodopa, according to the journal Clinical Medicine (2013) written by Worth mentions that “Levodopa in combination with the dopadeboxylase inhibitor benserazide (co-benelodopa) or carbidopa (co-caredopa) remains the most efficacious treatment for the motor symptoms of PD” (p. 93). Since Parkinson’s disease causes the loss of brain cells to produce dopamine. Dopamine is a chemical that is used for controlling movement. Without the production of dopamine in the brain, the patient has trouble with controlling their movement; their body may feel stiffness and tremors. Levodopa is used in early and advanced stages of Parkinson’s disease and it is used to help manage motor symptoms. Levodopa is a natural chemical that goes into the brain and is transformed into dopamine. This type of medication is used to treat tremors, spasms and poor muscle control of those who have Parkinson’s disease. Although Levodopa is used as a way to manage Parkinson’s disease, there are side effects to it as well. Some of the side effects that are listed in the journal The Australian Prescriber (2012) written by Sellbach and Silburn are as follows: “nausea, constipation, postural hypotension, hypersomnoience, sudden deep sleep episodes, impulse control disorders, hypersexuality, confusion and hallucinations” (p.184). To this day, Levodopa remains to be one of the most effective treatments of Parkinson’s disease.
The second prescription drug that is commonly used is called Dopamine agonists. Referring to Worth’s Clinical Medicine (2013), “Dopamine agonists in younger patients, DA’s may be the most preferred first-line therapy, as good evidence shows that motor complications are less common than with Levodopa” (p. 94). Dopamine agonists are used for patients who were newly diagnosed with Parkinson’s disease. This medication is what mimics dopamine, although the brain is not converting Dopamine agonists into dopamine, it acts as a dopamine (Worth, 2013, p. 94). Dopamine agonists also have side effects as stated in the journal The Australian Prescriber (2012) by Sellbach and Silburn, some of the side effects include “nausea, constipation, postural hypotension, hypersomnolence, sudden sleep episodes, impulse control...